Scleroderma, or systemic sclerosis (SSc
Introduction

1
Systemic sclerosis (SSc), or scleroderma, is a complex autoimmune disease associated 2 with significant morbidity and mortality. It is characterized by widespread fibrosis of 3 skin and internal organs, as well as vasculopathy [2] . The most common cause of death 4 in SSc is lung disease [3] . Roughly a quarter of people with SSc develop interstitial lung 5 disease, which involves lung fibrosis, vascular hyperreactivity, and inflammation [4] . 6 Another 7-13% of patients develop pulmonary arterial hypertension, which is 7 characterized by vascular injury and occlusion, vasoconstriction, and dysregulated 8 angiogenesis [4] . Both conditions lead to reduced lung function and increased risk of 9 death. The pathogenesis of lung disease in SSc is not understood well enough for 10 development of specific treatments, and current treatments rely primarily on 11 non-specific immune suppression [5] . There is a need to identify new molecular drivers 12 of lung disease in SSc, as well as how these drivers interact with other genes to influence 13 
pathogenesis.
14 A standard approach to discovering molecular drivers of lung disease in SSc is to 15 identify genetic variants associated with lung outcomes. Genetic studies have been 16 tremendously successful in identifying genetic variants associated with SSc and its 17 complications. In a reflection of the complexity of the disease, variants in over 200 genes 18 have been implicated in SSc risk and progression [1] , which has greatly increased our 19 understanding of the development of SSc [6] [7] [8] and may aid in personalized disease 20 monitoring and treatment [9] . The next step in this line of inquiry is to incorporate 21 genetic complexity into models that determine how variants interact with each other to 22 influence disease. By explicitly modeling genetic interactions, or epistasis, we can build 23 understanding of how molecular pathways work in concert to drive SSc pathology. 24 Initial studies of genetic interactions in SSc have been promising. Epistasis between 25 polymorphisms in the HLA region and cytokines has been shown to predict SSc risk [10] , 26 development of severe ventilatory restriction [11] , and digital ulcer formation [12] in SSc 27 patients. However, progress in this search is limited by a number of challenges. The 28 rarity of the disease and its clinical heterogeneity add to difficulties present in all human 29 genetic studies, such as low minor allele frequencies and the large number of potentially 30 relevant variants. Non-parametric tests such as Multifactor Dimensionality Reduction 31 (MDR) [13] have been successful in identifying the interactions that have been identified 32 thus far [10] [11] [12] . These findings suggest additional, complementary interaction analyses 33 may further dissect the genetic complexity of SSc and other common diseases. 34 Here we present a novel approach that increases the power to detect genetic 35 interactions in human genome-wide association studies (GWAS). We previously 36 developed the Combined Analysis of Pleiotropy and Epistasis (CAPE) to model 37 epistatic interactions [14, 15] . CAPE increases power to detect and interpret genetic 38 interactions by combining information across multiple traits into one consistent model. 39 We have demonstrated its ability to identify novel genetic interactions not detectable by 40 other methods [24, 26] . For this study, we combined CAPE with a filtering step, which 41 filtered the SNPs to those most likely to be involved in genetic interactions. We used Matrix Epistasis [16] , an ultra-fast method for exhaustively testing epistasis in 43 genome-wide SNP data. Candidate SNP pairs were then analyzed with CAPE and 44 significance was assessed with permutation tests. 45 We applied this approach to genetic and clinical data from a cohort of patients with 46 SSc (dbGaP accession phs000357.v2.p1). To capture aspects of lung disease and 47 autoimmunity, we analyzed two measures of lung function, forced vital capacity (FVC) 48 and diffusion lung capacity (DLC), as well as two autoantibody staining patterns: 49 centromeric, and nucleolar. Anti-centromere autoantibodies (ACA) are associated with 50 pulmonary hypertension, and anti-nucleolar autoantibodies (ANA) are associated with 51 progressive interstitial lung disease and pulmonary arterial hypertension [17] . Thus, 52 there may be common genetic pathways underlying both autoantibody status and lung 53 function that we can identify by analyzing all four traits simultaneously.
54
Results
55
Trait Descriptions
56
We analyzed a cohort of 416 patients with lung function and autoantibody 57 measurements (369 females and 47 males). The two lung traits, forced vital capacity
58
(FVCP) and diffusion lung capacity (DLCP), were measured as a percentage of the total 59 predicted by patient demographic parameters, such as age and weight [18] . Both traits 60 were roughly normally distributed, with maximum values greater than 100%, and the 61 traits were modestly correlated (Pearson's r = 0.48, p = 1.3 × 10 −25 ( Fig 1A) . We used 62 rank Z normalization on both traits before performing association tests. The 63 distribution of autoantibodies is shown in Fig 1A. About half of patients were negative 64 for both autoantibodies, while the other half were positive for one or the other. Only nor sex had any significant association with DLCP (all Student's t test p > 0.05).
72
We also looked for interactions between the autoantibodies and sex that influenced 73 the lung traits ( Fig 1C) . Presence of ANA and sex interacted nominally significantly to 74 influence FVCP (p = 0.042). In this interaction, females positive for ANA had lower value distributions from this analysis to investigate whether population structure in this 90 cohort might affect the SNP associations (Methods). There was no systematic effect of 91 population structure in this cohort (Fig S1) . We therefore did not use a correction for 92 population structure in this analysis.
93
The SNP association tests identified significant main effects in the HLA region 94 influencing the presence of ACA (Table 1) . One of these SNPs (rs9275390) is associated 95 with HLA-DBQ1 and was previously associated with positive ACA status in an SSc 96 GWAS [36] . Another SNP, rs660895, is associated with HLA-DRB1, and was previously 97 associated with risk of the autoimmune disease Rheumatoid Arthritis [37] . carcinogenesis, and many other processes. The SNP rs1449292 is located in an intron of 124 RBMS3. This gene encodes a member of a small family of proteins that bind 125 single-stranded RNA and DNA to regulate a wide range of biological processes. The 126 SNP rs792399 is located in an intron of MSI2 about which little is known. We focused 127 on this subnetwork, which we refer to as the "Wnt subnetwork," for the remainder of 128 the analysis. Interactions in the Wnt subnetwork were less than additive
98
SNP
130
The interactions in the Wnt subnetwork were suppressing (Fig 2A) . This means that in 131 the presence of the alternate allele at one locus, the phenotypic effects of the interacting 132 locus were suppressed. In this case, the suppressing interactions resulted 133 less-than-additive interactions. These effects can be seen in Fig 2C. The RBMS3 -MSI2 134 interaction primarily affected the two autoantibody traits. The alternate alleles of the 135 SNPs each had a negative effect on autoantibody presence. However, the effects of both 136 alternate alleles together was redundant and did not decrease autoantibody presence 137 beyond either of the individual alleles. The effects of this interaction on lung function
138
were not different from additive.
139
The RBMS3 -WNT5A interaction affected both lung function traits and ANA. The 140 effects on ANA were similar to the effects of the RBMS3 -MSI2 interaction: individual 141 alternate alleles decreased ANA incidence, but having two alternate alleles did not 142 further decrease incidence beyond that seen for a single alternate allele. For both lung 143 function traits, the WNT5A alternate allele had a large negative effect in the presence 144 of the RBMS3 reference allele, but this effect was completely suppressed in the presence 145 of the RBMS3 alternate allele. (Fig 3A) , supporting the hypothesis that the activity of 152 genes we identified genetically are aberrantly regulated in SSc. SNPs affecting the 153 expression of these genes may also affect SSc presentation. We could not assess the 154 differential expression of MSI2, as it was not present in the data set. To further investigate biological processes affected by the Wnt subnetwork, we searched 158 across GEO for genes that were co-regulated with the gene pairs in the Wnt subnetwork. 159 Genes with correlated expression often function together, and co-expression is frequently 160 used to elucidate gene function [34, [38] [39] [40] . We used this principle to identify possible 161 functional roles of the interactions in the Wnt subnetwork. To investigate whether the 162 interactions might be context-specific, we searched across multiple subsets of data sets 163 in GEO (Methods). For example, to identify lung-specific functions of each gene pair, 164 we searched for genes with correlated expression among data sets that were obtained 165 from lung tissue. To identify functions that were related to autoimmunity, we searched 166 only among data sets that analyzed autoimmune disease. All data set subsets are listed 167 in (Table 2) .
168
In each of these data set subsets, we queried the WNT5A-RBMS3 gene pair 169 separately from the RBMS3 -MSI2 gene pair. For each query, we identified sets of genes 170 whose expression was significantly correlated with the two query genes (p < 0.05), and 171 used the R package gProfileR [35] to look for functionally enriched GO terms in each 172 gene set. Multiple GO terms were significantly associated with the gene set from each 173 query. For a complete list of the enriched terms, see Supplementary Fig 1. To focus on 174 terms that are strongly related to SSc, we only analyzed GO terms that included the The −log 10 (p) for enriched GO terms in gene sets derived from SEEK (Methods). Each column shows results from a subset of the data sets on GEO. They are as follows: All -all data sets on GEO, Autoimmunedata sets studying autoimmunity, EMT -data sets studying epithelial to mesenchymal transition, Fibrosis -data sets studying fibrosis, ILD PAH -data sets studying interstitial lung disease (ILD) or pulmonary hypertension (PAH), Lung -data sets using lung tissue, Skin -data sets using skin tissue, SSc -data sets studying SSc. Each row shows the results for one GO term identified on the right-hand side. The GO terms are grouped functionally into six groups: collagen (green), extracellular matrix (purple), growth factor (orange), vascular (blue), wounding, (red), and Wnt signaling (yellow). The gene names at the top of the figure indicate that the left hand side of the figure shows results for the RBMS3 -MSI2 interaction, and the right side shows results for the RBMS3 -WNT5A interaction. The legend indicates how the colors of the cells relate to the −log 10 (p) of the term enrichment. Table 2 . The terms used to refine searches across gene expression data sets in GEO. Subsetting was performed either by selecting a pre-defined subset (categorical) or by using key words (keyword) (Methods). The final column indicates how many data sets were included when subset criteria were applied.
"vascular", "vaso", "wound", and "wnt" (Methods). These terms, and their enrichment p 177 values across all queries are shown in Fig 3B. 
178
Both gene pairs were significantly correlated with extracellular matrix (ECM) GO 179 terms across multiple tissue types and conditions (Fig 3) ; however, only the 180 RBMS3 -WNT5A pair was significantly correlated with genes involved in collagen 181 indicating that this pair may affect ECM through effects on collagen, whereas the 182 RBMS3 -MSI2 pair may influence ECM in a collagen-independent manner. The 183 RBMS3 -WNT5A pair also had multiple enrichments relating to growth factor activity, 184 particularly in lung tissue, and in lung disease (ILD PAH). This suggests that the pair 185 may be involved in growth factor signaling in a tissue-specific manner. All significant 186 enrichments for the RBMS3 -MSI2 interaction were in lung, lung disease, and 187 autoimmune conditions, suggesting that this interaction may be specific to lung tissue, 188 and may be aberrantly regulated in autoimmune conditions. The RBMS3 -WNT5A 189 interaction had significant enrichments in the data sets relating to fibrosis and EMT,
190
while the RBMS3 -MSI2 interaction did not, suggesting that the RBMS3 -WNT5A 191 interaction may be more functionally related to these processes than the RBMS3 -MSI2 192 interaction.
193
Discussion
194
We used a novel analytical approach to identify an epistatic interaction network 195 influencing lung function in patients with SSc. In this approach we used three strategies 196 to increase power to detect interactions in a patient cohort. First, we used a SNP 197 filtering step, to select the most highly epistatic and pleiotropic SNPs for further testing. 198 This step not only identified SNPs that were most likely to interact, but also 199 substantially reduced the number of statistical tests. Second, we combined information 200 across multiple related traits: two autoantibody traits, and two lung function traits.
201
And third, we decomposed the traits into orthogonal eigentraits and used only the top 202 two eigentraits in our study. This step reduced noise and captured mappable signals 203 that related to all four traits. Thus, using Matrix Epistasis to pre-filter SNPs combined 204 with CAPE allowed us to identify high-confidence genetic interactions in a relatively 205 small human cohort.
206
The resulting genetic interaction network contained a notable subnetwork consisting 207 of two interactions between three SNPs. Because the interactions in this network were 208 highly significant and because all three SNPs were located within gene bodies, we 
215
WNT5A, and Wnt signaling more generally, have been implicated in many processes 216 known to be involved in SSc pathogenesis [41] [42] [43] [44] , such as angiogenesis [45] , keratinocyte 217 differentiation and inflammation signaling [46] , and fibroblast proliferation [47] .
218
WNT5A has also been linked to cellular transdifferentiation, a family of processes by 219 which differentiated cell types dedifferentiate and redifferentiate into another cell type. 220 Transdifferentiation processes are critical for development, wound healing and tissue 221 regeneration [48] . However, when they are dysregulated, these processes contribute to 222 metastases in cancer, and widespread fibrosis seen in fibrotic diseases [48] . There are 223 three types of transdifferentiation that have been linked to fibrosis in SSc: epithelial to 224 mesenchymal transition (EMT) [49] , endothelial to mesenchymal transition 225 (EndoMT) [50] and adipocyte-myofibroblast transition (AMT) [51] .
226
Each of these processes has been hypothesized to be a source of excess 227 myofibroblasts in SSc tissues. Myofibroblasts differentiate from fibroblasts in response 228 to signaling from TGF-β, as well as other growth factors and cytokines. In healthy 229 individuals, myofibroblasts play an important role in wound healing. They contract to 230 close wounds and deposit ECM to seal wounds and to provide a scaffold for the 231 re-establishment of epithelial tissue. In SSc and other fibrotic disease however, there are 232 increased numbers of myofibroblasts with a concomitant increase in the deposition of 233 extracellular matrix, which causes tissue stiffening [49, 52] . EMT has been directly 234 implicated in lung fibrosis in mice [53, 54] , and may be an important source of 235 myofibroblasts in SSc skin [52] . Wnt signaling, and WNT5A in particular, has been 236 shown to mediate EMT in melanoma [55] and lung cancer [56] .
237
Endothelial to mesenchymal transition (EndoMT) has also been proposed to be a 238 source of myofibroblasts in SSc [50, 57, 58] . Originally thought only to occur in 239 developing embryos, EndoMT has been demonstrated to occur in adult cattle [59] and 240 mice [60] . TGF-β-induced EndoMT has since been shown to be involved in the 241 bleomycin model of pulmonary fibrosis as well as SSc-associated pulmonary 242 hypertension [58, 61] . Furthermore, there is evidence to suggest that Wnt signaling may 243 mediate EndoMT [58] .
244
The third transdifferentiation process to be proposed as a source of myofibroblasts in 245 SSc is AMT [51] . Marangoni et al. (2015) showed that when adipose-derived stem cells 246 from healthy donors were incubated with TGF-β, they lost markers of adipocytes, and 247 gained markers of myofibroblasts. In this experiment WNT5A was strongly upregulated 248 in the transitioning cells. signaling [62, 63] . By downregulating MMP2 and β-catenin, RBMS3 also inhibits 252 microvessel formation [64] . Loss of microvessels and reduced angiogenesis are hallmarks 253 of SSc [65, 66] . RBMS3 may also directly influence collagen synthesis [67, 68] , which is 254 highly upregulated in SSc. Although RBMS3 has not been directly linked to SSc, SNPs 255 in RBMS3 have been associated with risk of another autoimmune disease affecting 256 connective tissue called Sjögren's syndrome [69] .
257
Of the three top candidate genes, the least is known about MSI2, and it is most 258 studied in the context of cancer and its influence on EMT [70, 71] . MSI2 is upregulated 259 in metastatic-competent lung cancer cell lines, and aggressively metastatic patient 260 tumors have upregulated MSI2 [71] . Conversely, depletion of MSI2 resulted in reduced 261 metastatic potential [71] . As mentioned previously, EMT may be an important process 262 in SSc pathogenesis. MSI2 is also related to Wnt signaling and may influence 263 hepatocellular carcinoma outcomes through dysregulation of Wnt signaling [72] .
264
Thus, all three genes in the Wnt subnetwork have been implicated in mediating the 265 transdifferentiation process of epithelial to mesenchymal transition (EMT). Both
266
EMT [73] and EndoMT [58] Importantly, the Wnt subnetwork includes not only three novel candidate genes, but 284 also the genetic interactions between them. These interactions suggest functional 285 relatedness, which is broadly supported through connections in the literature with EMT 286 and Wnt signaling. But we can also make more direct connections between the specific 287 genes by using a more agnostic gene expression-based approach. We looked at genes can generate hypotheses about their specific involvement. For example, both gene pairs 294 were co-regulated with genes involved in ECM-related GO processes; however only genes 295 co-expresed with RBMS3 and WNT5A were associated with collagen, suggesting that 296 RBMS3 and MSI2 together may influence a distinct aspect of ECM. Interestingly, 297 functional enrichment of co-expressed genes also appeared to be context-specific.
298
SSc-related functional enrichments were seen predominantly in the lung and lung 299 disease (ILD PAH) data sets, as well as in autoimmunity data sets, but not in skin. We 300 interpret this to mean that both genetic interactions may be tissue-and disease-specific, 301 and that they were only detectable because we looked specifically at lung function 302 outcomes in an SSc cohort. Thus, the interactions we identified may not be related to 303 skin pathology. Validation experiments, therefore, should focus on lung tissue.
304
We further hypothesize that these interactions may be particularly important to 305 lung function in a disease state. All three SNPs we identified have high minor allele 306 frequencies in the general population (rs556874 MAF ≈ 0.4, rs1449292 MAF ≈ 0.5, and 307 rs792399 MAF ≈ 0.4) [76] . We hypothesize that these SNPs are unlikely to have any 308 measurable effect on lung function in healthy individuals, but that the interactions 309 between them become important in disease. We further hypothesize that because these 310 alleles are so common, they may not increase the risk of developing SSc, but that they 311 affect the course of the disease once established. Importantly, we performed our genetic 312 analysis on a cohort of patients with SSc that did not include controls. Although a detecting disease-specific interactions that would not be detectable in a data set that 316 included controls.
317
In this study we have taken a systems approach to identifying potential SSc-related 318 processes by analyzing genetic interactions that influence multiple disease traits 319 simultaneously. By addressing the complexity of this disease specifically in our models 320 we increased power to detect novel interactions among highly promising candidate genes. 321 The interactions, furthermore, may be disease-and tissue-specific. Identifying such 322 specific interactions may provide a promising avenue forward in drug target discovery. 323 The genes identified in this study are all widely expressed, and targeting them broadly 324 may result in unintended effects. However, because evidence suggests that the 325 interactions between the genes are tissue-and disease-specific, perhaps the interactions 326 themselves are better targets than the genes. For example, rather than attempting to 327 reduce WNT5A expression globally, a specific targeting of its interaction with RBMS3 328 may provide a novel approach to treating SSc-related lung disease without widespread 329 off-target effects. Known genetic interactions may also help predict disease course in 
Materials and Methods
339
Methods workflow
340
All code used for computational analyses in this paper are available in a supplemental 341 workflow available at https://github.com/annaLtyler/SSc_Epistasis_Workflow.
342
Genetic and clinical data
343
Genetic data and autoantibody status were obtained from the database of Genotypes 344 and Phenotypes (dbGaP) Accession phs000357.v1.p1.
345
The full data comprised 833 SSc patients, including 741 females and 85 males.
346
Genotypes were measured at 601,273 SNPs using the Human610 Quadv1 B platform. value based on factors such as age and sex [18] .
352
We analyzed two lung function traits, percent predicted forced vital capacity Expression data
358
We obtained gene expression data from the Gene Expression Omnibus (GEO) [19, 20] . 359 The data set we used (accession number GSE76808) compared gene expression in lung 360 March 14, 2019 12/21 biopsies taken from patients with SSc and interstitial lung disease (ILD) to biopsies of 361 healthy tissue from lung cancer patients undergoing surgical resection [21] . The 362 available data were log 2 normalized, and we did not perform further normalization.
363
Group-wise comparisons were performed with Student's two-sample t-tests.
364
SNP Filtering
365
We first reduced to 243,662 SNPs with minor allele frequency (MAF) ≥ 0.1, a relatively 366 high cutoff due to our pair-wise testing strategy. Because analysis of all pairwise 367 combinations of the filtered SNPs was computationally infeasible, we further filtered the 368 SNPs to the top 1500 SNPs that were most likely to participate in genetic interactions 369 influencing the four traits. For this filter we used Matrix Epistasis [16] , an ultra-fast 370 method of calculating interactions between SNPs. Using Matrix Epistasis, we were able 371 to calculate interaction scores for all SNP pairs exhaustively for each of the four traits. 372 We then used an iterative selection scheme to identify SNPs that were most epistatic 373 and most pleiotropic (affecting more than one trait). In the first stage of the search, we 374 identified SNP pairs that interacted significantly to influence more than one trait.
375
There were 52 pairs of SNPs interacted significantly (p < 1 × 10 −6 ) to affect both lung 376 traits. No other SNP pairs influences more than one trait. In the next stage of the 377 search, we looked for individual SNPs that were in epistatic interactions affecting more 378 than one trait, regardless of the interacting partner. For example, SNP1 might interact 379 with SNP2 to influence ANA, but interact with SNP3 to influence ACA. SNP1 affects 380 both traits through interactions, but by interacting with different partners. In this case, 381 we keep SNP1, but discard SNPs 2 and 3. We searched in this way for SNPs that 382 influenced all four traits as part of interactions, and then all three traits as part of 383 interactions, and so on until we had selected 1500 SNPs that were maximally epistatic 384 and pleiotropic.
385
Combined Analysis of Pleiotropy and Epistasis (CAPE)
386
We identified genetic interactions between SNPs using the Combined Analysis of 387 Pleiotropy and Epistasis (CAPE) [14, 15] . This method combines information across 388 multiple traits to infer directed genetic interactions. Combining information across 389 traits not only increases power to detect genetic interactions, but also allows inference 390 of the allele-to-allele direction of the interaction, which can be either positive 391 (enhancing) or negative (suppressing). We have applied this analysis to multiple model 392 organisms including yeast [15] , fly cell lines [22] , and mice [23] [24] [25] [26] . This is the first 393 application to human genetics.
394
As a preliminary analysis, we tested whether SNPs previously associated with SSc 395 could be recapitulated in this small cohort. We performed linear regression to associate 396 each SNP with each of the four traits.
397
We then decomposed the autoantibody and lung traits to four orthogonal eigentraits 398 (ETs) using singular value decomposition (SVD) (Fig 2) . This step concentrates trait 399 variance into composite ETs potentially improving the ability to map weak genetic 400 effects that are otherwise distributed across traits. We analyzed the first two ETs, 401 which explained 71% of the variance across all four phenotypes (Fig 2A) . These ETs 402 contrast each of the autoantibodies with the other autoantibody and the two lung traits 403 in turn (Fig 1A) .
404
We performed linear regression on pairs from the 1500 SNPs for each ET. (Supplementary Fig 1) . There was no systematic inflation of the estimates of 415 significance. We therefore did not correct for population structure in this study.
416
We used the regression coefficients to calculate CAPE parameters that recast 417 pair-wise epistasis as allele-to-allele influences that, in turn, modify allele-to-phenotype 418 main effects. This process is described in detail elsewhere [14, 15] , and we describe it 419 briefly here. The first step in calculating CAPE coefficients is a reparametrization of the 420 regression coefficients to obtain delta parameters (δ 1 and δ 2 ) which describe the degree 421 to which the presence of one SNP influences the phenotypic effects of the other SNP:
These parameters are then translated into directional (m 12 and m 21 ) coefficients 423 that self-consistently describe how the two SNPs influence one another:
Standard errors for these interaction terms were estimated by propagating standard 425 error terms from least squares regression with second-order Taylor expansion on the 426 regression parameters [15] .
427
Significance of the resulting model parameters were estimated through permutations 428 with family-wise error rate estimation. We generated a null distribution as follows: ETs 429 were randomly re-ordered relative to the genotypes, and we performed the single SNP 430 scan, and the pairwise scan as with the original data. We repeated this process until we 431 had generated a null distribution with 1.5 million values. We corrected empirical P 432 values using false discovery rate (FDR) [27] and used a significance threshold of 433 q < 0.05.
434
Assignment of SNPs to genes
435
To assign each SNP in the final network to a gene, we downloaded SNP annotations 436 from SNP Nexus [28] [29] [30] and assigned each gene to the nearest or containing gene.
437
Coexpression analysis
438
We used the Search-Based Exploration of Expression Compendium (SEEK) [31] to 439 identify genes that were co-regulated with genes identified by CAPE. SEEK is a web 440 tool (http://seek.princeton.edu) that searches across thousands of gene expression 441 data sets to find genes that are co-expressed with a user-defined query gene or gene set. 442 The search can be restricted to data sets in individual tissues or that have associated 443 keywords, thus providing context for the co-regulation.
444
Based on the CAPE results, we analyzed the two gene pairs: WNT5A and RBMS3 445 in one query and RBMS3 and MSI2 in another. Using SEEK, we searched for 446 co-regulated genes across all expression data sets. We also restricted our search to 447 subsets of data sets to identify co-regulated genes in particular contexts (Table 2) . For 448 example, to look for tissue-specific co-regulation, we searched for co-regulated genes in 449 all lung tissue data sets and all skin tissue data sets. Both tissues are relevant to SSc 450 pathogenesis. However, in this study, we identified genetic interactions associated with 451 lung function. We thus expected that genes co-regulated with the query genes in lung 452 would better reflect the function of each interaction in this study. In addition to 453 tissue-specific searches, we also searched for genes co-regulated with our query genes in 454 disease-specific data sets. To perform these searches, we restricted the search to data 455 sets associated with key words, for example autoimmunity and fibrosis.
456
In each of these queries, we identified the genes whose expression was significantly 457 correlated with the pair of query genes (p < 0.05). These gene sets represent genes that 458 are co-regulated with the query gene set across multiple tissues and disease contexts.
459
We propose that functional enrichments of these gene sets are related to the function of 460 the query gene pair in this disease cohort. To identify functional enrichment of each 461 gene set, we used gProfileR [35] (See workflow).
462
Among the significantly enriched terms, were many that are known to be related to 463 SSc, for example "extracellular matrix" and "wound healing." We were particularly 464 interested in enrichment for these terms that are known to be SSc-related and wanted 465 to compare enrichment in SSc-related terms across the different SEEK queries. To do 466 this, we looked only at enrichments of terms containing the following strings: "collagen", 467 "matrix", "fibroblast", "growth factor", "vascular", "vaso", "wound", and "wnt." This is 468 not an exhaustive list of the terms that are SSc-related, but is sufficient to to highlight 469 major differences between functional enrichments of the two gene pairs across different 470 contexts. deviations are a few significant p values in the HLA region for the ACA phenotype. We 486 concluded that there was no population structure in this population and did not use a 487 correction for population structure in our analysis. 
